This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
CARD Trial
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Advanced Bladder Cancer
JAVELIN Bladder 100 Trial
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Neal Shore, MD, FACS
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
APCCC 2022
AUA 2022
Upcoming
ASCO 2022
EAU 2022
See All
See All Conference Coverage
PCF
UroToday Home
Conference Highlights
AUA 2020
AUA 2020
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Bladder Health
BPH and Lower Urinary Tract Infections
COVID-19 and Genitourinary Cancers
Press Releases
AUA 2020 Bladder Cancer
Viewing 1-20 of 26 articles
AUA 2020: Identifying the Frequency of Actionable Genomic Alterations in Localized and Metastatic Upper Tract Urothelial Carcinoma
AUA 2020: Inherited Cancer Predisposition Gene Variants in Patients with Non-Muscle Invasive Bladder Cancer
AUA 2020: Cost-Effectiveness of Maintenance BCG for Intermediate and High Risk Non-Muscle Invasive Bladder Cancer
AUA 2020: Expanding Kidney-Sparing Options for Patients with Low-Grade Upper Tract Urothelial Cancer
AUA 2020: A Phase III Study to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec for Patients with High-Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer: Papillary Disease Cohort Results
AUA 2020: Patient Matched Genomic Analysis of High-Grade Non-Muscle Invasive Bladder Cancer Specimens Pre- and Post-BCG Immunotherapy
AUA 2020: Pain Management in Urologic Surgery
AUA 2020: Phase 3 Results Of Vicinium In BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
AUA 2020: Predictors of Postoperative Complications after Robotic And Open Radical Cystectomy: An Analysis From The RAZOR Trial
AUA 2020: State-of-the-Art Lecture: Probiotics and Microbiota in Urology – Beginning of the End or End of the Beginning?
AUA 2020: Association of Pathologic Response to Neoadjuvant Pembrolizumab with Tumor Subtype from the PURE-01 Study
AUA 2020: Planned Secondary Analysis of PURE-01: Role of FDG-PET/CT in Evaluating Lymph Node Involvement of Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Pembrolizumab and Radical Cystectomy
AUA 2020: Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery (ERAS) Protocols: A Systematic Review and Individual Patient Data Meta-Analysis
AUA 2020: Gender Based Variations in the Detection of Bladder Cancer with Blue Light Cystoscopy: Insights from a Multicenter Registry
AUA 2020: Role of Blue Light Cystoscopy in Detecting Invasive Bladder Tumor: Data from Multi-Institutional Registry
AUA 2020: Multi-Institutional Outcomes of Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Undergo Radical Cystectomy After BCG and Subsequent Salvage Intravesical Therapy
AUA 2020: Malignant Urinary Cytology of Unknown Origin: Blue Light Flexible Cystoscopy at the Outpatient Clinic May Be a Valuable Diagnostic Tool
AUA 2020: What to Do During BCG Shortage for High-Risk NMIBC Patients?
AUA 2020: Surgical Techniques: Tips & Tricks: Oncology: Bladder Cancer Blue Light Cystoscopy
AUA 2020: AUA Guidelines Case-Based Panel Discussion: Bladder Cancer (Non-Muscle and Muscle Invasive)
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free